i3

Maetrics announces Steve Cottrell as new president

Thursday, March 12, 2015 12:18 PM

Maetrics, a full-service life sciences consulting firm based in Indianapolis, Ind., has announced that Steve Cottrell, previously vice president of sales, will assume the role of company president.

More... »

Quest Diagnostics

inVentiv Health Clinical acquires equity stake in Mytrus

Wednesday, March 13, 2013 12:35 PM

inVentiv Health, based in Burlington, Mass., has taken an equity stake in Mytrus, a pioneer in virtual clinical trials and technologies including electronic informed consent to improve trial efficiency.

More... »


PharmaNet/i3 renamed inVentiv Health Clinical

Wednesday, January 30, 2013 11:07 AM

inVentiv Health,  a global provider of clinical, commercial and consulting services, announced that its existing CRO, PharmaNet/i3, will be renamed inVentiv Health Clinical. This renaming reflects the closer alignment between the clinical segment and inVentiv's commercial and consulting services.

More... »

Stansfield joins PharmaNet/i3 as executive vice president, clinical operations

Wednesday, December 19, 2012 11:39 AM

PharmaNet/i3, inVentiv Health’s clinical segment and a provider of clinical development services, has appointed Dr. Susan C. Stansfield as executive vice president of clinical operations for phase II-IV development in Europe, Middle East and Africa (EMEA), Asia-Pacific and Latin America. 

More... »

Former i3 CEO Bilawsky tapped to lead Precision Health Economics

Friday, October 19, 2012 02:55 PM

Health economics partnership Precision Health Economics (PHE) has named Glenn Bilawsky as its CEO. The healthcare consultancy, known for its exceptional, highly decorated and connected team has experienced rapid growth and is looking to Bilawsky to underpin its success with a strategy and business platform that will ensure stability while accelerating expansion of the business.

More... »

PharmaNet/i3 names VP and general manager, neuroscience

Monday, July 16, 2012 11:05 AM

PharmaNet/i3, inVentiv Health’s clinical segment, has appointed Robert Lasser, M.D., MBA, vice president and general manager, neuroscience, overseeing the management of all clinical projects handled by PharmaNet/i3’s neuroscience group and the Rater Training Services team. Dr. Lasser will be based in Princeton, N.J.

More... »

ACT Oncology names Julia Amo as COO

Wednesday, March 28, 2012 12:02 PM

ACT Oncology, a niche oncology service provider, has appointed Julia Amo, MBA, PMP, as chief operating officer.

More... »

ASLAN selects PharmaNet/i3 as strategic partner for oncology development

Tuesday, March 6, 2012 01:30 PM

ASLAN Pharmaceuticals has selected PharmaNet/i3, inVentiv Health’s clinical segment, as a strategic partner supporting the development of its oncology portfolio in Asia and conducting phase I and phase II clinical trials for two of ASLAN’s compounds.

More... »

Stephan Henauer to head i3 Pharma Resourcing in Europe

Monday, February 6, 2012 02:52 PM

PharmaNet/i3, inVentiv Health’s clinical segment, has appointed Stephan Henauer, M.D., executive director of i3 Pharma Resourcing. Henauer will lead the company’s staffing business in central, eastern and northern Europe.

More... »

Site group continues expansion toward East Coast

Monday, November 21, 2011 08:00 AM

The Pheonix, Ariz.-based site group Clinical Research Advantage (CRA) is expanding. 

More... »


CWWeekly

April 13

Quintiles-Quest Diagnostics joint venture latest in CRO-central lab deals, more could be on horizon

Biotech companies raise record amount of capital in Q1

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs